We found different frequencies of gene mutation and different levels of TpMs downregulation in malignant neoplasms as advanced bladder cancer, breast carcinomas and prostate cancer in respect to their healthy counterpart [10,13]. The gene discussed is TCHP; the disease is urinary bladder carcinoma.